(Q41254947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

GM-CSF promotes migration of human monocytes across the blood brain barrier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

Daphne Y S Vogel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Gijs Kooij

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Priscilla D A M Heijnen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Marjolein Breur

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Laura A N Peferoen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Paul van der Valk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Christine D Dijkstra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

3 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1808-1819

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Natalizumab: targeting alpha4-integrins in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Colony-stimulating factors in inflammation and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Functions of granulocyte-macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Systematic validation of specific phenotypic markers for in vitro polarized human macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

The distribution of granulocyte-macrophage colony-stimulating factor and its receptor in the developing human fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Granulocyte-macrophage colony-stimulating factor crosses the blood--brain and blood--spinal cord barriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Tumor necrosis factor-α disruption of brain endothelial cell barrier is mediated through matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Phenotyping primary human microglia: tight regulation of LPS responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Oxidative damage in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Enhanced number and activity of mitochondria in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Rho kinase inhibitor fasudil regulates microglia polarization and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Comparison of polarization properties of human adult microglia and blood-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

The impact of microglia-derived cytokines upon gliosis in the CNS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Human macrophage polarization in vitro: maturation and activation methods compared

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Enhancement of monocyte transendothelial migration by granulocyte-macrophage colony-stimulating factor: requirement for chemoattractant and CD11a/CD18 mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Blood-brain barrier-specific properties of a human adult brain endothelial cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Reactive oxygen species are required for the phagocytosis of myelin by macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Dihydrorhodamine 123: a fluorescent probe for superoxide generation?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444960

7 January 2021

Identifiers

DOI

10.1002/EJI.201444960

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25756873%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference